| |
|
|
|
Kaleido Biosciences Inc  
|
|
7.62 0.32 (0.04%) |
11-27 13:00 |
|
Open: |
7.33 |
Pre close: |
7.3 |
Target:
|
8.99 
|
|
High: |
7.6999 |
Low: |
7.25 |
Resistance:
|
7.70
8.99
|
|
Volume: |
32,890 |
Market Cap: |
274M |
Support:
|
6.46
5.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.30
|
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
6.90 |
Signal(12,26,9): |
-0.16 |
|
MA(100): |
7.28 |
Stochastic Oscillator |
%K(14,3):
|
82.20 |
|
MA(250): |
6.83  |
%D(3): |
79.63 |
|
Average Volume(K) |
3-Month: |
27578
|
52-Week |
High:
|
11.89 |
|
10-Days: |
8764 |
Low: |
2.82 |
|
RSI |
RSI(14):
|
56.60 |
Change(%): |
-14.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-2.160 |
P/E |
0.00 |
|
Sales Per Share |
0.007 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
1083.56 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
